You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Stay ENGAGED. More Visibility. More Options.
The EMBOTRAP® III Revascularization Device is designed for use in the anterior and posterior neurovasculature in vessels such as the internal carotid artery, the M1 or M2 segments of the middle cerebral artery, and basilar arteries. The EMBOTRAP Platform is indicated for vessels from 1.5mm to 6.5mm includes a distal end mesh and is the only dual layer design, designed to engage and grip the clot differently. EMBOTRAP® III Device has been shown to retrieve various thrombus types, whether fibrin-rich thrombus (hard) or RBC-rich thrombus types (soft).
Unique Dual Layer Design
The EMBOTRAP® III Revascularization Device has a unique dual layer design comprised of a segmented outer cage and inner channel to engage and grip clot differently. The segmented outer cage has multiple large inlet windows and cells that are designed to maintain wall apposition. The inner channel secures and stabilizes the thrombus to maintain engagement.
Distal closed end mesh
Maintains control of thrombus during retrieval.
Comprehensive Portfolio Across a Range of Vessel Sizes
Offered in a comprehensive portfolio of device lengths, the EMBOTRAP® III Revascularization Device is indicated for use in vessels as small as 1.5mm and as large as 6.5mm. The device seamlessly integrates into the CERENOVUS Stroke Solutions™ and is optimized for delivery through the PROWLER™ EX Microcatheter.
|Product Code||Name||Vessel Size Range||Microcatheter Compatibility||Working Length||Device Length|
- Smallest vessel indication compared to Solitaire™ X, Solitaire™ Platinum, Trevo™ NXT ProVue, Trevo™ XP ProVue, and Penumbra 3D™.
Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions.
Caution: US law restricts this device to sale by or on the order of a physician
This site is published by CERENOVUS which is solely responsible for its contents. It is intended for visitors from the United States.
© CERENOVUS 2022 Last Updated on 05/09/2022